CRYO-CELL INTERNATIONAL, INC. Contract with Customer, Asset, after Allowance for Credit Loss, Current
CRYO-CELL INTERNATIONAL, INC. (CCEL) had Contract with Customer, Asset, after Allowance for Credit Loss, Current of $892.37 thousand as of 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:ContractWithCustomerAssetNetCurrent · last filed 2026-07-15
- 2026-05-31: Contract with Customer, Asset, after Allowance for Credit Loss, Current $892.37K.
- 2026-02-28: Contract with Customer, Asset, after Allowance for Credit Loss, Current $874.56K.
- 2025-11-30: Contract with Customer, Asset, after Allowance for Credit Loss, Current $855.14K.
- 2025-08-31: Contract with Customer, Asset, after Allowance for Credit Loss, Current $831.46K.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss, Current | Contract with Customer, Asset, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-05-31 | $892.37K 10-Q · filed 2026-07-15 | |
| 2026-02-28 | $874.56K 10-Q · filed 2026-04-14 | |
| 2025-11-30 | $855.14K 10-Q · filed 2026-07-15 | |
| 2025-08-31 | $831.46K 10-Q · filed 2025-10-15 | |
| 2025-05-31 | $814.80K 10-Q · filed 2026-07-15 | |
| 2025-02-28 | $796.16K 10-Q · filed 2026-04-14 | |
| 2024-11-30 | $775.15K 10-Q · filed 2026-07-15 | |
| 2024-08-31 | $757.56K 10-Q · filed 2025-10-15 | |
| 2024-05-31 | $738.55K 10-Q · filed 2025-07-15 | |
| 2024-02-29 | $716.62K 10-Q · filed 2025-04-14 | |
| 2023-11-30 | $695.70K 10-K · filed 2026-02-27 | |
| 2023-08-31 | $675.65K 10-Q · filed 2024-10-15 | |
| 2023-05-31 | $654.12K 10-Q · filed 2024-07-15 | |
| 2023-02-28 | $633.97K 10-Q · filed 2024-04-15 | |
| 2022-11-30 | $615.63K 10-K · filed 2025-02-28 | |
| 2022-08-31 | $594.79K 10-Q · filed 2023-10-12 | |
| 2022-05-31 | $573.04K 10-Q · filed 2023-07-14 | |
| 2022-02-28 | $553.12K 10-Q · filed 2023-04-21 | |
| 2021-11-30 | $535.52K 10-K · filed 2024-02-28 | |
| 2021-08-31 | $519.54K 10-Q · filed 2022-10-18 | |
| 2021-05-31 | $499.63K 10-Q · filed 2022-07-11 | |
| 2021-02-28 | $478.37K 10-Q · filed 2022-04-13 | |
| 2020-11-30 | $466.14K 10-K · filed 2023-02-28 | |
| 2020-08-31 | $450.64K 10-Q · filed 2021-10-15 | |
| 2020-05-31 | $433.88K 10-Q · filed 2021-07-15 | |
| 2020-02-29 | $416.75K 10-Q · filed 2020-04-14 | |
| 2019-11-30 | $398.54K 10-K · filed 2022-02-22 | |
| 2019-08-31 | $383.40K 10-Q · filed 2020-10-15 | |
| 2019-05-31 | $329.23K 10-K · filed 2021-03-01 | $365.09K 10-Q · filed 2019-07-15 |
| 2019-02-28 | $345.76K 10-Q · filed 2019-04-15 | |
| 2018-11-30 | $329.23K 10-Q · filed 2020-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |